Marketplace: Canada's consumer watchdog, we've got your back. Watch Fridays at 8 p.m., 8:30 p.m. in Newfoundland and Labrador
Valeant Pharmaceuticals International Statements
Below is Valeant Pharmaceuticals International's response, dated Jan. 5, 2012, to Marketplace's questions about failed Cold-FX product and contamination:

No product failing to meet Health Canada criteria has ever been released for sale by the Company. Any products found not to meet quality standards are destroyed.

Regarding your question referring to 2008, I believe you are referring to a new potential product which was under development, and which was never commercialized. In that developmental product, the Company discovered the equally ubiquitous and benign E. hermannii (initially misidentified as E. Faecium). The development of this product-candidate was discontinued and therefore it never made it to market. Because this product was only developmental, it was not in the Company's inventory of distribution-ready product, and no formal records of its destruction exist. The discovery was, however, discussed with the Health Products and Food Branch Inspectorate to understand if there were any implications for commercialized product. In their resulting review, which included independent tests of randomly sampled lots, the Inspectorate found all COLD-FX samples to be well within their standards.


Valeant's response to further questions about contamination incident, dated Jan. 9, 2012:

- The developmental product-candidate was discontinued as the result of the discovery of bacteria in the product candidate.

- Concerns about the source of the bacteria were raised with Health Canada

- Health Canada conducted tests of a number of different lots and batches of COLD-FX

- Their tests discovered acceptable amounts of bacteria, including Eschericia Hermanii

- An assessment of the risk posed by this bacteria was conducted for its potential implications on the immune-compromised leukemia patients taking the product as part of their participation in a clinical trial on COLD-FX, as well as to the general public

- Dr. Kevin High, Chief of Infectious Diseases and Professor of oncology and hematology at Wake Forest (head investigator of the clinical trial) wrote "I don't think any of these cousins of E. coli are likely to cause illness in either immunocompetent or immunocompromised hosts" or individuals.

- Health Canada agreed with his assessment, and closed the issue on December 4 2009.
Broadcast Date: January 13, 2012
Recent Episodes
  • Canada has the highest rate of hospital acquired infections in the developed world, and Canada's consumer watchdog wants to know why. Erica Johnson puts hospital cleanliness to the test, and finds a mess that is making you sick.

  • Dirty Hospitals
  • Going on vacation? Think travel health insurance is going to protect you if something goes wrong? Erica Johnson investigates.

  • Tripped Up
  • In this special one-hour edition of 'Marketplace,' Tom Harrington tests the skills and ethics of home repair services.

  • When The Repairman Knocks
  • Why are prescription eyeglasses so darned expensive? In an eye-opening report, Tom Harrington focuses in on the outrageously high price of spectacles.

  • Framed
  • Tom Harrington and the 'Marketplace' team go undercover, targeting the dubious promises of a job search agency.

  • Recruitment Rip-Off
  • Tom Harrington reveals the story of how, for many unwilling clients, Canada's largest lawn care company has become a more invasive pest than the ones they promise to get rid of.

  • Snake In The Grass
  • Are all airline travel credits created equal? Erica Johnson investigates the credit policies of the top three Canadian airlines.

  • Busted - Air Canada
  • In this year's Top 10 countdown of Lousy Labels, Erica Johnson finds the truth behind the latest buzzwords on food packaging. It will make you think twice before filling up your shopping cart.

  • Lousy Labels: Health Hype
  • Are forest eco-labels worth the (toilet) paper they're printed on? Tom Harrington investigates.

  • The Toilet Paper Chase
  • 'Marketplace' blows the roof off of one of Canada's worst landlords. Tom Harrington exposes renter horror stories, and asks: How can the company get away with this?

  • What FX?
  • It's Canada's top-selling cold remedy, but does COLD-FX really do what the company claims? Erica Johnson puts it to the test. Also, what does Don Cherry have to say?

  • What FX?
  • 'Marketplace' launches our 39th season with a special one-hour episode that takes on Canada's major store chains.

  • Canada's Worst Customer Service
  • 'Marketplace' showcases its new season, and updates a story we first reported last year on the potential risk of popular birth control pills.

  • Spinning A Pill (Update)